Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ultragenyx Pharmaceutical Inc. buy Canaccord Genuity Group Inc.

Ultragenyx Pharmaceutical Inc.
Start price
€17.40
18.02.26 / 50%
Target price
€66.69
18.02.27
Performance (%)
24.66%
Price
?
20.08.26
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr currently has a performance of 24.66%. This prediction currently runs until 18.02.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ultragenyx Pharmaceutical Inc. 9.794% 9.794%
iShares Core DAX® -1.059% 5.007%
iShares Nasdaq 100 -2.387% 0.864%
iShares Nikkei 225® -4.361% 1.211%
iShares S&P 500 -1.778% 1.391%

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) 24.66%
Target price 66.692
Change
Ends at 18.02.27

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $128.00 to $79.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat

Canaccord Genuity Group Inc. 
0
Report Share
18.02.26

Stopped prediction by Canaccord_Genuity_Gr for Ultragenyx Pharmaceutical Inc.

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€21.69
20.08.26
€71.06
20.08.27
0.00%
20.08.26

Canaccord Genuity Group Inc. 
20.08.26 50%